Overexpression of δ-catenin is associated with a malignant phenotype and poor prognosis in colorectal cancer

Zhang,Hong; Dai,Shun‑Dong; Liu,Shu‑Li; Zhang,Fang‑Yuan; Dai,Chao‑Liu

doi:10.3892/mmr.2015.3918

Overexpression of δ-catenin is associated with a malignant phenotype and poor prognosis in colorectal cancer

Authors:
- Hong Zhang
- Shun‑Dong Dai
- Shu‑Li Liu
- Fang‑Yuan Zhang
- Chao‑Liu Dai
View Affiliations

Affiliations: Department of Colorectal Surgery, Shengjing Hospital, China Medical University, Shenyang, Liaoning 110004, P.R. China, Department of Pathology, The First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: June 11, 2015 https://doi.org/10.3892/mmr.2015.3918
Pages: 4259-4265
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Little is known regarding the expression or clinical significance of δ-catenin, a member of the catenin family, in colorectal cancer (CRC). The present study examined the expression of δ-catenin using immunohistochemistry in 110 cases of CRC, including 70 cases with complete follow‑up records and 40 cases with paired lymph node metastases. In addition, δ‑catenin mRNA and protein expression were compared in 30 pairs of matched CRC and normal colorectal tissues by reverse transcription quantitative polymerase chain reaction and western blot analysis. δ‑Catenin was weakly expressed or absent in the cytoplasm of normal intestinal epithelial cells, whereas positive δ‑catenin expression localized to the cytoplasm was observed in CRC cells. The rate of positive δ‑catenin expression in CRC (68.18%; 75/110) was significantly higher than that in normal colorectal tissues (36.7%; 11/30; P<0.001). In addition, δ‑catenin mRNA and protein expression were significantly increased in CRC tissues compared to those in their matched normal tissues (all P<0.05). The expression of δ‑catenin in stage III‑IV CRC was higher than that in stage I‑II CRC, and the expression of δ‑catenin in the tumors of patients with lymph node metastases was higher than that in patients without lymph node metastases. Kaplan‑Meier survival curves demonstrated that the survival time of patients with positive δ‑catenin expression was shorter than that of patients with negative δ‑catenin expression (P=0.005). Furthermore, Cox multivariate analysis indicated that the tumor, nodes and metastasis stage (P=0.02) and positive δ-catenin expression (P=0.033) were independent prognostic factors in CRC. The present study therefore indicated that δ-catenin may be a suitable independent prognostic factor for CRC.

View Figures

View References

1	Boedefeld WM II, Bland KI and Heslin MJ: Recent insights into angiogenesis, apoptosis, invasion and metastasis in colorectal carcinoma. Ann Surg Oncol. 10:839–851. 2003. View Article : Google Scholar : PubMed/NCBI
2	Gumbiner BM: Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 6:622–634. 2005. View Article : Google Scholar : PubMed/NCBI
3	Makrilia N, Kollias A, Manolopoulos L and Syrigos K: Cell adhesion molecules: Role and clinical significance in cancer. Cancer Invest. 27:1023–1037. 2009. View Article : Google Scholar : PubMed/NCBI
4	Paffenholz R and Franke WW: Identification and localization of a neurally expressed member of the plakoglobin/armadillo multigene family. Differentiation. 61:293–304. 1997. View Article : Google Scholar : PubMed/NCBI
5	Zhou J, Liyanage U, Medina M, Ho C, Simmons AD, Lovett M and Kosik KS: Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport. 8:2085–2090. 1997. View Article : Google Scholar : PubMed/NCBI
6	Tanahashi H and Tabira T: Isolation of human delta-catenin and its binding specificity with presenilin 1. Neuroreport. 10:563–568. 1999. View Article : Google Scholar : PubMed/NCBI
7	Burger MJ, Tebay MA, Keith PA, Samaratunga HM, Clements J, Lavin MF and Gardiner RA: Expression analysis of delta-catenin and prostate-specific membrane antigen: Their potential as diagnostic markers for prostate cancer. Int J Cancer. 100:228–237. 2002. View Article : Google Scholar : PubMed/NCBI
8	Lu Q, Dobbs LJ, Gregory CW, Lanford GW, Revelo MP, Shappell S and Chen YH: Increased expression of delta-catenin/neural plakophilin-related armadillo protein is associated with the down-regulation and redistribution of E-cadherin and p120ctn in human prostate cancer. Hum Pathol. 36:1037–1048. 2005. View Article : Google Scholar : PubMed/NCBI
9	Zhang JY, Wang Y, Zhang D, Yang ZQ, Dong XJ, Jiang GY, Zhang PX, Dai SD, Dong QZ, Han Y, et al: delta-Catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm. J Pathol. 222:76–88. 2010.PubMed/NCBI
10	Dai SD, Wang Y, Zhang JY, Zhang D, Zhang PX, Jiang GY, Han Y, Zhang S, Cui QZ and Wang EH: Upregulation of δ-catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer. Cancer Sci. 102:95–103. 2011. View Article : Google Scholar
11	Sobin LH and Wittekind C: Colon and rectum. TNM classification of malignant tumors. 6th edition. New York: Wiley, John & Sons; pp. 72–76. 2002
12	Bosman FT, Carneiro F, Hruban RH and Theise ND: WHO Classification of Tumors of the Digestive System. 4th edition. IARC press; Lyon: 2010
13	Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, et al: The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 55:611–622. 2009. View Article : Google Scholar : PubMed/NCBI
14	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar
15	Lu Q, Paredes M, Medina M, Zhou J, Cavallo R, Peifer M, Orecchio L and Kosik KS: delta-catenin, an adhesive junction-associated protein which promotes cell scattering. J Cell Biol. 144:519–532. 1999. View Article : Google Scholar : PubMed/NCBI
16	Jones SB, Lanford GW, Chen YH, Morabito M, Kim K and Lu Q: Glutamate-induced delta-catenin redistribution and dissociation from postsynaptic receptor complexes. Neuroscience. 115:1009–1021. 2002. View Article : Google Scholar : PubMed/NCBI
17	Martinez MC, Ochiishi T, Majewski M and Kosik KS: Dual regulation of neuronal morphogenesis by a delta-catenin-cortactin complex and Rho. J Cell Biol. 162:99–111. 2003. View Article : Google Scholar : PubMed/NCBI
18	Kim K, Sirota A, Chen YH, Jones SB, Dudek R, Lanford GW, Thakore C and Lu Q: Dendrite-like process formation and cytoskeletal remodeling regulated by delta-catenin expression. Exp Cell Res. 275:171–184. 2002. View Article : Google Scholar : PubMed/NCBI
19	Paffenholz R, Kuhn C, Grund C, Stehr S and Franke WW: The arm-repeat protein NPRAP (neurojungin) is a constituent of the plaques of the outer limiting zone in the retina, defining a novel type of adhering junction. Exp Cell Res. 250:452–464. 1999. View Article : Google Scholar : PubMed/NCBI
20	Lu Q, Mukhopadhyay NK, Griffin JD, Paredes M, Medina M and Kosik KS: Brain armadillo protein delta-catenin interacts with Abl tyrosine kinase and modulates cellular morphogenesis in response to growth factors. J Neurosci Res. 67:618–624. 2002. View Article : Google Scholar : PubMed/NCBI
21	Lu Q, Abdul A, Chen YH, et al: δ-Catenin has the potential to promote the proliferation/survival and invasiveness of human cancer cells. Mol Biol Cell. 14:3412003a.
22	Kim K, Oh M, Ki H, Wang T, Bareiss S, Fini ME, Li D and Lu Q: Identification of E2F1 as a positive transcriptional regulator for delta-catenin. Biochem Biophys Res Commun. 369:414–420. 2008. View Article : Google Scholar : PubMed/NCBI
23	Wang T, Chen YH, Hong H, Zeng Y, Zhang J, Lu JP, Jeansonne B and Lu Q: Increased nucleotide polymorphic changes in the 5′-untranslated region of delta-catenin (CTNND2) gene in prostate cancer. Oncogene. 28:555–564. 2009. View Article : Google Scholar :